Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

June 30, 2020June 30, 2020

GBT to Request Oxbryta’s Approval in Europe for SCD Patients 12 and Older

News

Global Blood Therapeutics (GBT) plans to submit a marketing authorization application to the European Medicines Agency (EMA) asking that Oxbryta (voxelotor) be approved for treating hemolytic anemia in people ... Read more

June 11, 2020June 11, 2020

GBT to Request That Oxbryta Treat Children Starting at Age 4

News

Global Blood Therapeutics (GBT) will ask the U.S. Food and Drug Administration (FDA) to allow children with sickle cell disease (SCD), ages 4 to 11, to also be treated with Oxbryta (voxelotor). The company ... Read more

April 21, 2020April 21, 2020

FDA Grants Orphan Drug Designation to FT-4202 for Sickle Cell Treatment

News

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Forma Therapeutics‘ FT-4202 for the treatment of sickle cell disease (SCD) This designation is given to investigational therapies intended ... Read more

March 10, 2020March 10, 2020

Lack of Vitamin D in SCD Children Linked to Worse Hospital Outcomes in Study

News

Children and adolescents with sickle cell disease (SCD) who lack vitamin D are hospitalized more often due to pain crises, have longer hospital stays, and make more frequent visits ... Read more

March 5, 2020March 5, 2020

Hematology Society Releases Guidelines for Blood Transfusions in SCD

News

The American Society of Hematology released new clinical guidelines on the use of blood transfusions in people with sickle cell disease (SCD). The transfusion guidelines are the second in ... Read more

October 22, 2019October 22, 2019

Voxelotor May Reduce Severity and Number of Leg Ulcers, Trial Analysis Suggests

News

Voxelotor can reduce the severity of existing leg ulcers and the incidence of new ones in people with sickle cell disease (SCD), new clinical trial results suggest. The findings ... Read more

September 24, 2019September 24, 2019

Emergency Department Less Likely to Provide Recommended Care for VOEs, Study Finds

News

Children with sickle cell disease (SCD) who arrive at an emergency department with vaso-occlusive episodes (VOEs) are more likely to have a longer delay before treatment, receive less narcotics ... Read more

August 15, 2019August 15, 2019

New Technology May Allow for Better Monitoring of Sickle Cell Disease

News

A new way to monitor blood cells that doesn’t require microscopic imaging or biochemical markers may allow for better management of sickle cell disease, a study suggests. The study, ... Read more

June 11, 2019June 11, 2019

GBT Awards $200K in ACCEL Grants to Improve SCD Healthcare Delivery

News

Global Blood Therapeutics (GBT) announced the five organizations that will receive more than $200,000 worth of grants through its new Access to Excellent Care for Sickle Cell Patients Pilot ... Read more